{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T12:10:01Z","timestamp":1749816601562,"version":"3.41.0"},"reference-count":33,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Neurourology and Urodynamics"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>This study aimed to compare the recommendations on therapy from currently available guidelines on non\u2010neurogenic daytime urinary incontinence (DUI) in children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a systematic search for guidelines on non\u2010neurogenic DUI in children. We extracted the therapy recommendations from all the guidelines for a descriptive comparison.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eight guidelines were included. All guidelines advise urotherapy as the first step of treatment in children with DUI. They all agree on the importance of addressing co\u2010existing bowel dysfunction and urinary tract infections. Neuromodulation was recommended as an early treatment modality in three guidelines, while the others reserve it for special cases (<jats:italic>n<\/jats:italic>\u2009=\u20092) or do not mention it at all (<jats:italic>n<\/jats:italic>\u2009=\u20093). Pharmacotherapy with anticholinergics is often recommended, sometimes when urotherapy is insufficient, and by some guidelines simultaneously. The use of newer beta\u20103\u2010agonists was only mentioned by recently (2019 and 2021) published guidelines. Only half of the guidelines mentioned the level of evidence with their recommendations, and when mentioned, the quality of the evidence is generally low.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Overall, the recommendations for treating non\u2010neurogenic DUI in children are generally consistent, with all the guidelines endorsing urotherapy as the initial treatment. However, differences exist regarding additional treatments such as neuromodulation and pharmacotherapy, both areas of active research with evolving insights. The observed differences can be explained by the publication date of the guidelines and the target audience. The evidence supporting the recommendations is generally of low quality, indicating a need for further research in the field of DUI in children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>As this is a review, no clinical trial registration was conducted. The review protocol has been registered in PROSPERO (CRD42021149059).<\/jats:p><\/jats:sec>","DOI":"10.1002\/nau.70046","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T05:12:37Z","timestamp":1743743557000},"page":"1180-1187","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Critical Appraisal of Guidelines for Daytime Urinary Incontinence in Children: Comparison of Recommendations on Treatment"],"prefix":"10.1002","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0383-7354","authenticated-orcid":false,"given":"J. Marleen","family":"Linde","sequence":"first","affiliation":[{"name":"Department of Primary and Long\u2010Term Care University of Groningen, University Medical Center Groningen Groningen the Netherlands"},{"name":"Department of Urology Isala Zwolle the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"Hofmeester","sequence":"additional","affiliation":[{"name":"Department of Urology Maasziekenhuis Pantein Beugen the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn G.","family":"Steffens","sequence":"additional","affiliation":[{"name":"Department of Urology Isala Zwolle the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis J.","family":"Kloosterman\u2010Eijgenraam","sequence":"additional","affiliation":[{"name":"Department of Paediatrics Isala Zwolle the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rien J. M.","family":"Nijman","sequence":"additional","affiliation":[{"name":"Department of Urology University of Groningen, University Medical Center Groningen Groningen the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1086-8730","authenticated-orcid":false,"given":"Marco H.","family":"Blanker","sequence":"additional","affiliation":[{"name":"Department of Primary and Long\u2010Term Care University of Groningen, University Medical Center Groningen Groningen the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,4]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-016-0928-0"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(19)30113-0"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0b013e32833cb84a"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2008.028043"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92244-n"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22911"},{"key":"e_1_2_13_8_1","unstructured":"C.Radmayr G.Bogaert H. S.Dogan et al. EAU Guidelines on Pediatric Urology (2019) 2020 https:\/\/uroweb.org\/guidelines\/paediatric-urology."},{"key":"e_1_2_13_9_1","unstructured":"M.Kamphuis J.Deurloo M.Beltman F.Leerdamvan A.Bulk\u2010Bunschoten andC.Wierenga\u2010van der Hoeven NCJ zindelijkheid van urine en feces (2011) 2020 https:\/\/www.jgzrichtlijnen.nl\/richtlijn\/jgz-richtlijn-zindelijkheid-van-urine-en-feces\/."},{"key":"e_1_2_13_10_1","unstructured":"NSW Government Young People With Urinary Incontinence \u2013 Health Professional Guide (2018) https:\/\/aci.health.nsw.gov.au\/__data\/assets\/pdf_file\/0009\/404793\/ACI-Urology-Young-people-incontinence-guide.pdf."},{"key":"e_1_2_13_11_1","unstructured":"NVU NVK CV&V Richtlijn Urine incontinentie bij kinderen (2008) https:\/\/richtlijnendatabase.nl\/richtlijn\/urine-incontinentie_bij_kinderen\/urine-incontinentie_kinderen_-_korte_beschrijving.html."},{"key":"e_1_2_13_12_1","unstructured":"Deutsche Gesellschaft f\u00fcr Kinder\u2010 und Jugendpsychiatrie Psychosomatik und Psychotherapie (DGKJP) Deutsche Gesellschaft f\u00fcr Kinder\u2010 und Jugendmedizin (DGKJ): Interdisziplin\u00e4re S2k\u2010Leitlinie: Enuresis und nicht\u2010organische (funktionelle) Harninkontinenz bei Kindern und Jugendlichen (May 31 2021) accesed 3 2024 https:\/\/register.awmf.org\/assets\/guidelines\/028-026l_S2k_Enuresis-und-nicht-organische-funktionelle-Harninkontinenz_2021-12.pdf."},{"key":"e_1_2_13_13_1","unstructured":"Svenska Enuresakademien Handl\u00e4ggning av urininkontinens datid hos barn (2019) accessed 2 2020 https:\/\/svenskaenures.se\/home\/hur_far_jag_hjalp.html."},{"key":"e_1_2_13_14_1","unstructured":"The Royal Children's Hospital Melbourne. Urinary Incontinence \u2013 Daytime Wetting accessed 3 2020 https:\/\/www.rch.org.au\/clinicalguide\/guideline_index\/Urinary_Incontinence_-_Daytime_wetting\/."},{"key":"e_1_2_13_15_1","unstructured":"AGREE Next Steps Consortium. The AGREE II instrument (2017) http:\/\/www.agreetrust.org."},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.70047"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22751"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012367.pub2"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.21140"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.06.039"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.24601"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-024-04006-8"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2024.07.006"},{"volume-title":"GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations","year":"2013","author":"Sch\u00fcnemann H.","key":"e_1_2_13_24_1"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2021.11.013"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.11.060"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2019.10.013"},{"key":"e_1_2_13_28_1","unstructured":"European Medicines Agency. European Medicines Agency \u2013 Betmiga accessed July 31 2024 https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/betmiga."},{"key":"e_1_2_13_29_1","unstructured":"U.S. Food and Drug Administration. FDA Approval Betmiga accessed July 31 2024 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2012\/202611Orig1s000TOC.cfm."},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.24928"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002361"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/CU9.0000000000000124"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2023.10.034"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.70047"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.70046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T11:43:09Z","timestamp":1749814989000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.70046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1002\/nau.70046"],"URL":"https:\/\/doi.org\/10.1002\/nau.70046","archive":["Portico"],"relation":{},"ISSN":["0733-2467","1520-6777"],"issn-type":[{"type":"print","value":"0733-2467"},{"type":"electronic","value":"1520-6777"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-11-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}